We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes Guidance on Collecting Race, Ethnicity Data in Clinical Trials
FDA Publishes Guidance on Collecting Race, Ethnicity Data in Clinical Trials
The FDA is recommending that sponsors submit more detailed race and ethnicity data with their applications, compared to recommendations from a previous international harmonization guideline.